TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response Meeting Abstract
| Authors: | Isakoff, S. J.; Goss, P. E.; Mayer, E. L.; Traina, T. A.; Carey, L. A.; Krag, K.; Rugo, H. S.; Liu, M. C.; Stearns, V.; Come, S. E.; Borger, D. R.; Quadrino, C. A.; Finkelstein, D.; Garber, J. E.; Ryan, P. D.; Winer, E. P.; Ellisen, L. W.; on behalf of theTranslational Breast Cancer Research Consortium |
| Abstract Title: | TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880300164 |
| DOI: | 10.1200/jco.2011.29.15_suppl.1025 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract : 1025 -- Source: Wos |
